Pathway-based microarray analysis for robust disease classification

Neural Computing and Applications

Volumn 21, Issue 4, 2012, Pages 649-660

  Sootanan, Pitak ^a   Prom on, Santitham ^a   Meechai, Asawin ^a   Chan, Jonathan H ^a  

^a KING MONGKUT'S UNIVERSITY OF TECHNOLOGY THONBURI   (Thailand)

Author keywords

Discriminative score; Disease classification; Microarray analysis; Negatively correlated feature sets; Pathway activity; Phenotype correlated genes

Indexed keywords

ACTIVITY INFERENCE; BREAST CANCER; CLASSIFICATION BOUNDARY; DATA SETS; DISCRIMINATIVE SCORE; DISEASE CLASSIFICATION; DISEASE DIAGNOSIS; DISEASE STATE; EXPRESSION PROFILE; FEATURE SETS; HIGH-THROUGHPUT TECHNOLOGIES; MICROARRAY ANALYSIS; MICROARRAY EXPRESSIONS; PATHWAY MARKERS; ROBUST MODELS;

GENES;

DIAGNOSIS;

EID: 84861200177     PISSN: 09410643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00521-011-0662-y     Document Type: Article

References (23)

1. Golub TR, Slonim DK, Tamayo P, Huard C, Gassenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
2. Berns A (2000) Cancer: gene expression diagnosis. Nature 403: 491-492.
3. Dupuy A, Simon RM (2007) Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J Natl Cancer Inst 99: 147-157.
4. Zheng C-H, Chong Y-W, Wang H-Q (2011) Gene selection using independent variable group analysis for tumor classification. Neural Comput Appl 20: 161-170. doi: 10. 1007/s00521-010-0513-2.
5. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
6. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-D484.
7. Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A (2006) Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5: 55.
8. Guo Z, Zhang T, Li X, Wang Q, Xu J, Yu H, Zhu J, Wang H, Wang C, Topol EJ, Wang Q, Rao S (2005) Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics 6: 58. doi: 10. 1186/1471-2105-6-58.
9. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi M-B, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
10. Lee E, Chuang H-Y, Kim J-W, Ideker T, Lee D (2008) Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4(11): e1000217. doi: 10. 1371/journal. pcbi. 1000217.
11. Kim K-J, Cho S-B (2006) Ensemble classifiers based on correlation analysis for DNA microarray classification. Neurocomputing 70: 187-199.
12. Sootanan P, Prom-on S, Meechai A, Chan JH (2010) Microarray-based disease classification using pathway activities with negatively correlated feature sets. In: Wong KW, Mendis BSU, Bouzerdoum A (eds) 17th international conference on neural information processing, (ICONIP 2010), part II, vol 6444. LNCS, Sydney, pp 250-258.
13. Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedrén S, Bergh J (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7(6): R953-R964.
14. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EMJJ, Atkins D, Foekens JA (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
15. Edgar R, Domrachev M, Lash AE (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
16. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH (2009) The WEKA data mining software: an update. SIGKDD Explor 11(1): 10-18. doi: 10. 1145/1656274. 1656278.
17. Liao JG, Chin KV (2007) Logistic regression for disease classification using microarray data: model selection in a large p and small n case. Bioinformatics 23(15): 1945-1951.
18. Helman P, Veroff R, Atlas SR, Willman C (2004) A Bayesian network classification methodology for gene expression data. J Comput Biol 11(4): 581-615.
19. Ringnér M, Peterson C (2003) Microarray-based cancer diagnosis with artificial neural networks. BioTechniques 34: S30-S35.
20. McDonald JH (2009) Handbook of biological statistics, 2nd edn edn. Sparky House Publishing, Baltimore, pp 198-201.
21. Esteban LM, Sanz G, López FJ, Borque Á, Vergara JM (2006) Logistic regression versus neural networks for medical data. Monografias del Seminario Matemático García de Galdeano 33: 245-252.
22. Stewart B (1998) Improving performance of naïve Bayes classifiers by including hidden-variables. In: Mira J, Del Pobil AP (eds) Methodology and tools in knowledge-based systems, 11th international conference on industrial and engineering applications of artificial intelligence and expert systems, IEA/AIE-98, vol I. Lecture Notes in Computer Science, vol 1415, Springer, Berlin, pp 272-280.
23. Pirooznia M, Yang JY, Yang MQ, Deng Y (2008) A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics 9(Suppl 1): S13.